Moreover, abnormal expression of MHC I on tumor cells and upregulation of PD-L1 are associated with poor prognosis in Hodgkin lymphoma patients, thus suggesting that immune response is independent of T-cells, inhibited by PD-1, and rescued by PD-L1 blockade (Mulder et al., 2022). Here, PDCD1 is linked to neoplasm.